Mikhail Eydelman Vaxcyte, Inc. (PCVX) insider trading activity

Mikhail Eydelman is SVP, GEN COUNSEL & CORP SEC of Vaxcyte, Inc.. Currently has a direct ownership of 41,620 shares of PCVX, which is worth approximately $1.37 Million. The most recent transaction as insider was on Jul 01, 2024, when has been sold 1,667 shares (Common Stock) at a price of $21.41 per share, resulting in proceeds of $35,690. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.6K

47.47% 3M change

36.03% 12M change

Total Value Held $1.37 Million

Mikhail Eydelman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 01 2024	BUY Exercise of conversion of derivative security	$35,690 $21.41 p/Share	1,667 Added 4.88%	32,493 Common Stock
Jun 07 2024	SELL Payment of exercise price or tax liability	$23,774 $70.97 p/Share	335 Reduced 1.08%	30,826 Common Stock
Jun 03 2024	SELL Open market or private sale	$120,724 $72.42 p/Share	1,667 Reduced 5.08%	31,161 Common Stock
Jun 03 2024	BUY Exercise of conversion of derivative security	$35,690 $21.41 p/Share	1,667 Added 4.83%	32,828 Common Stock
May 01 2024	SELL Open market or private sale	$103,987 $62.38 p/Share	1,667 Reduced 5.17%	30,597 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	$35,690 $21.41 p/Share	1,667 Added 4.91%	32,264 Common Stock
Apr 01 2024	SELL Open market or private sale	$111,689 $67.0 p/Share	1,667 Reduced 5.17%	30,597 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	$35,690 $21.41 p/Share	1,667 Added 4.91%	32,264 Common Stock
Mar 02 2024	SELL Payment of exercise price or tax liability	$43,860 $71.55 p/Share	613 Reduced 1.96%	30,597 Common Stock
Mar 01 2024	SELL Open market or private sale	$123,024 $73.8 p/Share	1,667 Reduced 5.07%	31,210 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	$35,690 $21.41 p/Share	1,667 Added 4.83%	32,877 Common Stock
Feb 29 2024	BUY Grant, award, or other acquisition	-	10,500 Added 25.17%	31,210 Common Stock
Feb 01 2024	SELL Open market or private sale	$122,891 $73.72 p/Share	1,667 Reduced 7.45%	20,710 Common Stock
Feb 01 2024	BUY Exercise of conversion of derivative security	$35,690 $21.41 p/Share	1,667 Added 6.93%	22,377 Common Stock
Jan 02 2024	SELL Open market or private sale	$106,021 $63.6 p/Share	1,667 Reduced 7.45%	20,710 Common Stock
Jan 02 2024	BUY Exercise of conversion of derivative security	$35,690 $21.41 p/Share	1,667 Added 6.93%	22,377 Common Stock
Dec 07 2023	SELL Payment of exercise price or tax liability	$18,453 $56.78 p/Share	325 Reduced 1.55%	20,710 Common Stock
Dec 07 2023	SELL Open market or private sale	$565,000 $56.5 p/Share	10,000 Reduced 32.22%	21,035 Common Stock
Dec 07 2023	BUY Exercise of conversion of derivative security	$214,100 $21.41 p/Share	10,000 Added 24.37%	31,035 Common Stock
Oct 02 2023	SELL Open market or private sale	$1,008,199 $50.41 p/Share	20,000 Reduced 49.4%	20,487 Common Stock
Oct 02 2023	BUY Exercise of conversion of derivative security	$428,200 $21.41 p/Share	20,000 Added 33.06%	40,487 Common Stock
Sep 05 2023	SELL Payment of exercise price or tax liability	$60,639 $51.0 p/Share	1,189 Reduced 5.49%	20,487 Common Stock
Jun 07 2023	SELL Payment of exercise price or tax liability	$33,056 $51.25 p/Share	645 Reduced 2.89%	21,676 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	13,750 Added 38.7%	21,782 Common Stock
Jun 07 2022	BUY Grant, award, or other acquisition	-	7,500 Added 50.0%	7,500 Common Stock

Mikhail Eydelman

SVP, GEN COUNSEL & CORP SEC

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Value

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vaxcyte, Inc.

Track Activities on PCVX

Account